P900033/S117: INTEGRA Dermal Regeneration Template, Integra Meshed Dermal Regeneration Template, and Integra Omnigraft Dermal Rege
The record for P900033/S117 describes a 30-Day Notice supplement to PMA P900033, filed by Integra Lifesciences Corp. for the wound and burn interactive dressing product code MGR. The stated purpose is installation and qualification of a new Water for Injection (WFI) pretreatment, generation, storage, and distribution system, filed under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The decision is OK30, dated 2026-09-18.
The source statement identifies only the WFI system scope; it does not name the manufacturing site, the equipment vendor, qualification protocols, or any effect on the finished device. As a supplement to an existing PMA, it is not a new approval of the whole device system, and the notice itself is not evidence of safety or clinical effectiveness. Specifics about the prior WFI system and what changed relative to it are absent from the supplied fields.
FDA approval-order wording
installation and qualification of a new Water for Injection (WFI) pretreatment, generation, storage, and distribution system









